Home
Bausch & Lomb

Bausch & Lomb Market Share Analysis for July 2026

Bausch & Lomb is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products.

Industry: N/A

Domainbausch.co.nz

Year Founded1853

Employees> 10001

Annual Revenue> $1B

Bausch & Lomb

Bausch & Lomb (including company regionals)

bausch.co.nz

See more website traffic and engagement information

Bausch & Lomb Revenue up to July 2026 is > 1B

revenue generated by Bausch & Lomb top domains

Bausch & Lomb top domains revenue over 3 years

Revenue for Bausch & Lomb top domains

bausch.co.nz> 1B

See more with Sales Intelligence

Bausch & Lomb Stock price in July 2026

Bausch & Lomb stock is traded under the ticker #BLCO. Below you can review Bausch & Lomb stock performance in the past 12 months up to July 2026

Total visits to Bausch & Lomb's top domains

Understand Bausch & Lomb market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

bausch.co.nz--

See more with Sales Intelligence

Avg. visit duration in Bausch & Lomb's top domains

Analyze Bausch & Lomb engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

bausch.co.nz--

See more with Sales Intelligence

Avg. pageviews on Bausch & Lomb's top domains

See how Bausch & Lomb keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

bausch.co.nz--

See more with Sales Intelligence

Bausch & Lomb top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Bausch & Lomb

These are the website technologies, by industry, used by Bausch & Lomb top domains

Advertising (3)

Google Adsense

Conversion & Analytics (2)

Google Analytics

Audio Video Media (1)

YouTube

Marketing (1)

Google Marketing Platform

More Technologies

4

See all

News & Signals from Bausch & Lomb

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBausch & Lomb Incorporated acquires Novartis Pharmaceuticals Corporation for $2.5B.Topping the list was a potential $2.5bn deal under which Bausch & Lomb acquired Novartis' Xiidra (lifitegrast ophthalmic solution) for signs and symptoms of dry eye disease; investigational compounds SAF312 (libvatrep) for chronic ocular surface pain and OJL332 for an undisclosed ophthalmic indication; plus rights to use the AcuStream delivery device in dry eye indications.